Continuation of Oral ONC201 in Treating Patients With Advanced Solid Tumors

NCT02324621 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

26

Enrollment

OTHER

Sponsor class

Conditions

Unspecified Adult Solid Tumor

Interventions

DRUG: Oral ONC201
OTHER: pharmacological study
OTHER: laboratory biomarker analysis

Sponsor

Rutgers, The State University of New Jersey

Collaborators

[object Object]
[object Object]
[object Object]